Thermal proteome profiling (TPP) reveals NAMPT as the anti-glioma target of phenanthroindolizidine alkaloid PF403.

Li F, Zhang Z, Shi Q, Wang R, Ji M, Chen X, Li Y, Liu Y, Yu S.

Open source

DOI
10.1016/j.apsb.2025.02.027
Published
2025-02-26
Container
Acta Pharm Sin B
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.apsb.2025.02.027,
  title = {Thermal proteome profiling (TPP) reveals NAMPT as the anti-glioma target of phenanthroindolizidine alkaloid PF403.},
  author = {Li F and  Zhang Z and  Shi Q and  Wang R and  Ji M and  Chen X and  Li Y and  Liu Y and  Yu S.},
  year = {2025},
  journal = {Acta Pharm Sin B},
  doi = {10.1016/j.apsb.2025.02.027},
  url = {https://doi.org/10.1016/j.apsb.2025.02.027}
}

RIS

TY  - JOUR
TI  - Thermal proteome profiling (TPP) reveals NAMPT as the anti-glioma target of phenanthroindolizidine alkaloid PF403.
AU  - Li F
AU  -  Zhang Z
AU  -  Shi Q
AU  -  Wang R
AU  -  Ji M
AU  -  Chen X
AU  -  Li Y
AU  -  Liu Y
AU  -  Yu S.
PY  - 2025
JO  - Acta Pharm Sin B
DO  - 10.1016/j.apsb.2025.02.027
UR  - https://doi.org/10.1016/j.apsb.2025.02.027
ER  - 

APA

F, L., Z, Z., Q, S., R, W., M, J., X, C., Y, L., Y, L., & S., Y. (2025). Thermal proteome profiling (TPP) reveals NAMPT as the anti-glioma target of phenanthroindolizidine alkaloid PF403.. Acta Pharm Sin B. https://doi.org/10.1016/j.apsb.2025.02.027

Source records